SRZN Earnings & Financial Statements
Surrozen, Inc.
$23.75
+$0.24(+1.02%)
54
Overall
40
Value
83
Tech
39
Quality
Market Cap
$279.15M
Volume
631.59K
52W Range
$11.39 - $37.83
Target Price
$45.00
SRZN earnings and financial statements: Surrozen, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SRZN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.48M | $10.65M | - | $12.50M | - |
| Operating income | -$42.09M | -$25.54M | -$45.78M | -$44.34M | -$54.39M |
| EBITDA | -$239.72M | -$60.64M | -$40.60M | -$42.38M | -$52.33M |
| Net income | -$242.03M | -$63.56M | -$43.04M | -$36.00M | -$54.65M |
| EPS (diluted) | $-32.37 | $-21.67 | $-21.33 | $-15.60 | $-33.15 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $98.73M | $48.47M | $46.08M | $89.44M | $137.17M |
| Total liabilities | $286.49M | $69.85M | $8.14M | $13.43M | $27.47M |
| Shareholders’ equity | -$187.76M | -$21.38M | $37.94M | $76.00M | $109.70M |
| Cash and equivalents | $89.20M | $34.56M | $36.04M | $24.69M | $33.09M |
| Long-term debt | $5.35M | $6.64M | $882.0K | $3.38M | $5.60M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$30.20M | -$17.60M | -$40.40M | -$44.15M | -$48.81M |
| Capital expenditure | -$128.0K | -$26.0K | -$398.0K | -$728.0K | -$1.27M |
| Free cash flow | -$30.33M | -$17.63M | -$40.80M | -$44.87M | -$50.08M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SRZN | $23.75 | +1.0% | 631.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |